Evidence map›Paper›PMID 20335318›Full record

ArticleAmerican journal of physiology. Renal physiology2010

P2X(1) receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo.

David A Osmond, Edward W Inscho

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 40 citations in OpenAlex.

  1. Targeting P2X Receptors-Current Progress in Sepsis.International journal of inflammation · 2025
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. The dark side of extracellular ATP in kidney diseases.Journal of the American Society of Nephrology : JASN · 2015
    Review
  14. Renal autoregulation in health and disease.Physiological reviews · 2015
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David A OsmondDepartment of Physiology, Medical College of Georgia, Augusta, Georgia 30912, USA.
Edward W Inscho
Augusta University · US

Funding

TLR4 in the Regulation of Renal Microvascular FunctionR01DK044628 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI INSCHO, EDWARD W · 2000 to 2021
$6.2M
The Inflammatory Cytokines, MCP-1 and TGF-Beta, Mediate Renal Autoregulatory ImpaR01HL098135 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI INSCHO, EDWARD W · 2010 to 2014
$1.8M
PURINERGIC REGULATION OF THE RENAL MICROVASCULATURER29DK044628 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI INSCHO, EDWARD W. · 1994 to 1998
–
NHLBI NIH HHS R01 HL098135NIDDK NIH HHS DK-044628NIDDK NIH HHS R01 DK044628NIDDK NIH HHS R29 DK044628PHS HHS NHLBI-00070
6 · The paper itself

Abstract

In vitro experiments demonstrate that P2X(1) receptor activation is important for normal afferent arteriolar autoregulatory behavior, but direct in vivo evidence for this relationship occurring in the whole kidney is unavailable. Experiments were performed to test the hypothesis that P2X(1) receptors are important for autoregulation of whole kidney blood flow. Renal blood flow (RBF) was measured in anesthetized male Sprague-Dawley rats before and during P2 receptor blockade with PPADS, P2X(1) receptor blockade with IP5I, or A(1) receptor blockade with DPCPX. Both P2X(1) and A(1) receptor stimulation with alpha,beta-methylene ATP and CPA, respectively, caused dose-dependent decreases in RBF. Administration of either PPADS or IP5I significantly blocked P2X(1) receptor stimulation. Likewise, administration of DPCPX significantly blocked A(1) receptor activation to CPA. Autoregulatory behavior was assessed by measuring RBF responses to reductions in renal perfusion pressure. In vehicle-infused rats, as pressure was decreased from 120 to 100 mmHg, there was no decrease in RBF. However, in either PPADS- or IP5I-infused rats, each decrease in pressure resulted in a significant decrease in RBF, demonstrating loss of autoregulatory ability. In DPCPX-infused rats, reductions in pressure did not cause significant reductions in RBF over the pressure range of 100-120 mmHg, but the autoregulatory curve tended to be steeper than vehicle-infused rats over the range of 80-100 mmHg, suggesting that A(1) receptors may influence RBF at lower pressures. These findings are consistent with in vitro data from afferent arterioles and support the hypothesis that P2X(1) receptor activation is important for whole kidney autoregulation in vivo.

Indexed as

Purinergic P2 Receptor AntagonistsAdenosineAdenosine A1 Receptor AgonistsAdenosine A1 Receptor AntagonistsAdenosine TriphosphateAnimalsArteriolesBlood PressureDinucleoside PhosphatesDose-Response Relationship, DrugHomeostasisKidneyMalePurinergic P2 Receptor AgonistsPyridoxal PhosphateRats1,3-dipropyl-8-cyclopentylxanthineAdenosineAdenosine A1 Receptor AgonistsAdenosine A1 Receptor AntagonistsAdenosine Triphosphatealpha,beta-methyleneadenosine 5'-triphosphatediinosine pentaphosphateDinucleoside PhosphatesN(6)-cyclopentyladenosinePurinergic P2 Receptor AgonistsPurinergic P2 Receptor AntagonistsPyridoxal Phosphatepyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidReceptor, Adenosine A1Receptors, Purinergic P2Receptors, Purinergic P2XXanthines

Identifiers

PMID20335318
PMCPMC2886815
OpenAlexW2109598130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.